| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/02/1997 | WO1997035538A2 Tumor necrosis factor alpha convertase |
| 10/02/1997 | WO1997026331A3 Use of neuronal apoptosis inhibitor protein (naip) |
| 10/02/1997 | DE19612645A1 Dimethyl-substituierte Cyclohexandienderivate Dimethyl-substituted Cyclohexandienderivate |
| 10/02/1997 | CA2250241A1 Arylamino fused pyridines and pyrimidines |
| 10/02/1997 | CA2250186A1 Method for treating migraine pain |
| 10/02/1997 | CA2249985A1 Tumour necrosis factor alpha convertase |
| 10/02/1997 | CA2249598A1 Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives |
| 10/02/1997 | CA2249580A1 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof |
| 10/02/1997 | CA2248874A1 Tetrahydro-beta-carboline compounds |
| 10/02/1997 | CA2248873A1 Method for treating pain |
| 10/01/1997 | EP0798000A2 Treating disorders by application of insulin-like growth factors and analogs |
| 10/01/1997 | EP0797993A1 Compostions comprising l-carnitine or derivatives thereof and antioxidants |
| 10/01/1997 | EP0797992A2 Use of taurine, homotaurine and/or methionine for inducing analgesia or anesthesia and treating or preventing ischaemic injury |
| 10/01/1997 | EP0797990A2 Use of steroid antagonists for the treatment and prophylaxis of dementia-related disorders |
| 10/01/1997 | EP0797677A1 Adenoviral-vector-mediated gene transfer into medullary motor neurons |
| 10/01/1997 | EP0797593A2 Improved cyclic crf antagonists |
| 10/01/1997 | EP0797590A1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 10/01/1997 | EP0797583A1 Tachykinin antagonists |
| 10/01/1997 | EP0797454A1 Improved adenoviral vectors and producer cells |
| 10/01/1997 | EP0797445A2 Use of bioassimilable boron compounds for the control of subviral pathogenic agents |
| 10/01/1997 | EP0797441A1 Pharmaceutical composition comprising lamotrigine |
| 10/01/1997 | EP0797439A1 Use of pramipexole as a neuroprotective agent |
| 10/01/1997 | EP0797435A1 Controlled release matrix for pharmaceuticals |
| 10/01/1997 | EP0707587B1 Pharmacologically active enantiomers |
| 10/01/1997 | CN1161041A Heterocycle-condensed morphinoid derivatives |
| 10/01/1997 | CN1161039A Novel melatonin agonist 'beta'-carboline derivatives and analogs with a naphthalenic structure, method for their preparation and their use as drugs |
| 10/01/1997 | CN1160998A Method of inhibiting conditions associated with neuropeptide Y |
| 10/01/1997 | CN1160571A Compound Chinese medicine preparation for curing traumatic paraplegia and its preparation technology |
| 10/01/1997 | CN1160569A Chinese medicine for curing trigeminal neuralgia and its preparation process |
| 10/01/1997 | CN1036009C Derivative of 2-(thien-2-yl) imidazo(2,1-b)-benzothiazole-3-acetic acid, preparation and pharmaceutical application of same |
| 09/30/1997 | US5672709 Heterocyclic compounds and their preparation and use |
| 09/30/1997 | US5672707 9-aminoacridine derivatives possessing psychotropic, antiamnestic and lipid-regulative activity |
| 09/30/1997 | US5672705 Antiischemic agents treating nervous system disorders, huntington' disease, alzheimer's disease, parkinson's disease |
| 09/30/1997 | US5672618 Protein kinase C inhibitors |
| 09/30/1997 | US5672608 Acenaphthyl substituted guanidines and methods of use thereof |
| 09/30/1997 | US5672602 Substituted piperazine derivatives |
| 09/30/1997 | US5672584 Modified with end groups |
| 09/30/1997 | US5672508 Polypeptide comprising cyclin dependent kinase binding motifs from two or more proteins |
| 09/30/1997 | US5672360 24-hour sustained release dosage of morphine or morphine sulfate |
| 09/30/1997 | US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles |
| 09/30/1997 | CA2091686C Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anesthesia of eyes, based thereon |
| 09/25/1997 | WO1997035007A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | WO1997034901A1 Piperidine derivatives |
| 09/25/1997 | WO1997034900A1 Azaspiro derivatives |
| 09/25/1997 | WO1997034899A1 Heterocyclic compounds and their preparation and use |
| 09/25/1997 | WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 09/25/1997 | WO1997034884A1 Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 09/25/1997 | WO1997034883A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 09/25/1997 | WO1997034878A1 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 09/25/1997 | WO1997034626A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034624A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | WO1997034618A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | WO1997034603A1 USE OF (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL IN TREATING DEPRESSIVE DISORDERS AND BIPOLAR DISORDERS |
| 09/25/1997 | WO1997034602A1 Paroxetine in treatment of depression |
| 09/25/1997 | WO1997034587A2 Transdermal device |
| 09/25/1997 | WO1997034567A2 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/25/1997 | WO1997027220A3 Substrates and inhibitors for cysteine protease ich-1 |
| 09/25/1997 | CA2250016A1 Piperidine derivatives |
| 09/25/1997 | CA2249555A1 Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
| 09/25/1997 | CA2249368A1 Administration of polypeptide growth factors following central nervous system ischemia or trauma |
| 09/25/1997 | CA2249196A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | CA2249179A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 09/25/1997 | CA2248573A1 Transdermal device |
| 09/25/1997 | CA2248153A1 Heterocyclic compounds and their preparation and use |
| 09/25/1997 | CA2247940A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 09/25/1997 | CA2220914A1 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 09/24/1997 | EP0796858A1 Triazole antifungal agents |
| 09/24/1997 | EP0796849A1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof |
| 09/24/1997 | EP0796619A1 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 09/24/1997 | EP0796322A1 Production and use of human and plant methyltransferases |
| 09/24/1997 | EP0796275A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 09/24/1997 | EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/24/1997 | EP0796258A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
| 09/24/1997 | EP0796251A1 Uracil derivatives |
| 09/24/1997 | EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 09/24/1997 | EP0796103A1 Use of incense in the treatment of alzheimer's disease |
| 09/24/1997 | EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| 09/24/1997 | EP0673245B1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
| 09/24/1997 | EP0521985B1 Chimeric antibodies with receptor binding ligands in place of their constant region |
| 09/24/1997 | CN1160400A Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 09/24/1997 | CN1160396A Carboxylic acid derivs., their preparation and their use |
| 09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
| 09/24/1997 | CN1160042A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1159915A Neuroprotective agents |
| 09/24/1997 | CN1035944C Method for preparing 3-aminopiperidine derivs. and related nitrogen-contg. heterocycles |
| 09/24/1997 | CN1035939C Substd. (arylalkylaminobenzyl) aminopropionamide derivs., their preparation method |
| 09/24/1997 | CN1035938C Substd. (arylalkoxybenzyl) aminopropanamide derivs. their preparation method |
| 09/23/1997 | US5670640 Chemical condensation and cyclization using alkyllithium, alkoxides, lithium hexamethyldisilazide |
| 09/23/1997 | US5670634 Inhibit expression of peptide of alzheimer's disease and down's syndrome |
| 09/23/1997 | US5670546 N-Arylalkylphenylacetamide derivatives |
| 09/23/1997 | US5670540 Triglycerides of fatty acids |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/23/1997 | US5670525 Substituted 4-phenyl-6-amino-nicotinic acid compounds useful in the treatment of CNS disorders |
| 09/23/1997 | US5670524 Methods and compositions for the treatment of pain utilizing ropivacaine |
| 09/23/1997 | US5670522 Fused ring heterocycle, treatment of schizophrenia |
| 09/23/1997 | US5670519 Acenaphthyl-substituted guanidines and methods of use thereof |
| 09/23/1997 | US5670516 Excitatory amino acid receptor antagonists |
| 09/23/1997 | US5670511 Indolepiperidine derivatives |
| 09/23/1997 | US5670505 Tachykikin antagonist for respiratory diseases, ophthalmic diseases and antiinflammatory agents |